Related Experiment Videos
[Immunological principles of polysaccharide-protein conjugate vaccination]
Insights
Young children poorly respond to polysaccharide vaccines. Conjugate vaccines, linking polysaccharides to proteins, improve immune responses and antibody production in infants.
Area of Science:
- Immunology
- Bacteriology
Background:
- Encapsulated bacteria like Haemophilus influenzae and Streptococcus pneumoniae pose infection risks.
- Antibodies against bacterial capsular polysaccharides are crucial for defense.
- Infants under two years exhibit poor immune responses to polysaccharide antigens, unlike protein antigens.
Purpose of the Study:
- To investigate the reasons behind the age-dependent immunodeficiency in young children against T-independent polysaccharide antigens.
- To evaluate the efficacy of conjugate vaccines in overcoming this unresponsiveness.
Main Methods:
- The study contrasts the immunogenicity of polysaccharide antigens versus protein antigens in young children.
- It discusses the role of T-dependent and T-independent immune responses.
- The mechanism of conjugate vaccines, linking capsular polysaccharide to carrier proteins, is examined.
Main Results:
- Young children show a limited or absent immune response to purified capsular polysaccharide antigens.
- Protein antigens, such as tetanus and diphtheria toxoids, are effective immunogens in this age group.
- Haemophilus conjugate vaccines elicit a T-dependent immune response, enhancing immunogenicity in infants.
Conclusions:
- A functional immaturity of B-cell populations likely causes unresponsiveness to T-independent polysaccharide antigens in young children.
- Haemophilus conjugate vaccines are highly immunogenic in children under two years.
- These vaccines induce robust antibody production and immunological memory against encapsulated bacteria.
Abstract:
Haemophilus influenzae and Streptococcus pneumoniae are bacteria with a polysaccharide capsule. The production of specific antibodies against capsular polysaccharide plays a pivotal role in the defence against these organisms. However, children under the age of two years do not at all or only poorly respond to an infection with encapsulated bacteria or after vaccination with purified capsular polysaccharide antigen. In contrast, protein antigens, e.g. tetanus- and diphtheriae-toxoid, are good immunogens in this age group. The difference between polysaccharide antigen and protein antigen is that the former are T-dependent antigens whereas the latter are T-independent. The reason for this age dependent "immunodeficiency" is not clear. A functional immaturity of a B-cell population seems to be the reason for the unresponsiveness of young children against Ti-2 antigens. The Haemophilus conjugate vaccine contains the capsular polysaccharide chemically conjugated to a carrier protein. This results in an immune response against the polysaccharide with characteristics of a T dependent antigen, giving high immunogenicity even in children under the age of two years, resulting in high antibody-production and the induction of immunological memory.